R
TWST icon

Rebalance’s Twist Bioscience TWST Stock Holding History

Rebalance’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$206K Buy
+2,000
New +$130K 0.01% 102

Other funds holding TWST

PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
MNBTD
Moody National Bank Trust Division Galveston, Texas $1.21B AUM 38.93% 1-Year Est. Return
EOJOAM
E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
NS
NBC Securities Birmingham, Alabama $1.48B AUM 31.07% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
ICP
Interchange Capital Partners Pittsburgh, Pennsylvania $532M AUM 26.57% 1-Year Est. Return

Rebalance's TWST Position: Q2 2026 in Review

Rebalance opened a new position in Twist Bioscience (TWST) in Q2 2026: 2,000 shares worth $206K. The stake represents 0.01% of the portfolio and ranks #102 among its holdings.

30 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Rebalance held 2,000 shares of Twist Bioscience worth $206K as of Q2 2026.
  • Twist Bioscience was a new Rebalance position in Q2 2026.
  • Twist Bioscience made up 0.01% of Rebalance's portfolio in Q2 2026, its #102 holding.
  • 30 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Rebalance's 13F filing for Q2 2026, filed 16 Jul 2026.